225 related articles for article (PubMed ID: 21109987)
21. Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice.
Peluso JJ; Gawkowska A; Liu X; Shioda T; Pru JK
Endocrinology; 2009 Nov; 150(11):4846-54. PubMed ID: 19797399
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
Li Y; Li W; Yang Y; Lu Y; He C; Hu G; Liu H; Chen J; He J; Yu H
Brain Res; 2009 Aug; 1286():13-8. PubMed ID: 19559015
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
24. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
[TBL] [Abstract][Full Text] [Related]
27. A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy.
Satoh M; Minami Y; Takahashi Y; Tabuchi T; Nakamura M
J Card Fail; 2011 Nov; 17(11):923-9. PubMed ID: 22041329
[TBL] [Abstract][Full Text] [Related]
28. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
[TBL] [Abstract][Full Text] [Related]
31. Target identification of microRNAs expressed highly in human embryonic stem cells.
Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
[TBL] [Abstract][Full Text] [Related]
32. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
Xiong J; Du Q; Liang Z
Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro.
Rosario R; Blenkiron C; Shelling AN
Gynecol Oncol; 2013 Apr; 129(1):209-15. PubMed ID: 23280087
[TBL] [Abstract][Full Text] [Related]
34. miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant.
Zhou Q; Haupt S; Prots I; Thümmler K; Kremmer E; Lipsky PE; Schulze-Koops H; Skapenko A
J Immunol; 2013 Jun; 190(12):6579-88. PubMed ID: 23650616
[TBL] [Abstract][Full Text] [Related]
35. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
Peluso JJ; Liu X; Saunders MM; Claffey KP; Phoenix K
J Clin Endocrinol Metab; 2008 May; 93(5):1592-9. PubMed ID: 18319313
[TBL] [Abstract][Full Text] [Related]
36. Progesterone Receptor Membrane Component 1 (PGRMC1) Expression in Murine Retina.
Shanmugam AK; Mysona BA; Wang J; Zhao J; Tawfik A; Sanders A; Markand S; Zorrilla E; Ganapathy V; Bollinger KE; Smith SB
Curr Eye Res; 2016 Aug; 41(8):1105-1112. PubMed ID: 26642738
[TBL] [Abstract][Full Text] [Related]
37. [Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian cancer cells in vitro].
Ye H; Chen J; Huang X; Guo A; Hao P
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1752-7. PubMed ID: 23268403
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells.
Chen J; Wang L; Matyunina LV; Hill CG; McDonald JF
Gynecol Oncol; 2011 Apr; 121(1):200-5. PubMed ID: 21277012
[TBL] [Abstract][Full Text] [Related]
39. Progestin and AdipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1), and PGRMC2 and Their Role in Regulating Progesterone's Ability to Suppress Human Granulosa/Luteal Cells from Entering into the Cell Cycle.
Sueldo C; Liu X; Peluso JJ
Biol Reprod; 2015 Sep; 93(3):63. PubMed ID: 26203174
[TBL] [Abstract][Full Text] [Related]
40. Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.
Panda H; Chuang TD; Luo X; Chegini N
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1316-26. PubMed ID: 22492871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]